ROBIN HOGUE: Open Payments
NPI 1518957810 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 7 payments from 5 companies in 2025. Trend: 2023 $586 · 2024 $427 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $90 |
| ABBVIE INC. | 3 | $66 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: CAPLYTA, VRAYLAR, Auvelity, UZEDY, REXULTI.
Industry payments across LA — which companies pay providers there.
